silica gel and eluted with hexanes/EtOAc (2/1) to give 6 (2.65 g,
temperature overnight, and concentrated under reduced pressure.
The residue was dissolved in anhydrous CH2Cl2, treated with EtN-
(i-Pr)2 (4.0 mL, 23 mmol, 10 equiv), and then cooled to 0 °C before
acetyl chloride (1.34 mL, 18.6 mmol, 8 equiv) was added. After
warming to room temperature, the resulting solution was poured
into saturated aqueous NaHCO3 solution, the organic layer was
separated, the aqueous layer was extracted twice with CH2Cl2, and
the combined organic phase was washed with brine, dried over Na2-
SO4, and concentrated under reduced pressure. The residue was
purified by chromatography on silica gel eluting with EtOAc/
1
3.6 mmol, 97%): [R]20 ) -50 (c 6.7, CHCl3); H NMR (500
D
MHZ, CDCl3) δ 5.59 (dt, J ) 4.5, 11.0 Hz, 1H), 5.31 (dd, J ) 2.0,
10.5 Hz, 1H), 5.28 (s, broad, 1H), 5.08 (d, J ) 9.0 Hz, 1H), 4.92
(d, J ) 12.5 Hz, 1H), 4.70 (t, J ) 10.5 Hz, 1H), 4.17 (dd, J ) 9.0,
12.5 Hz, 1H), 3.78 (s, 3H), 2.57 (dd, J ) 5.0, 13.5 Hz, 1H), 2.29
(s, 3H), 2.01 (s, 3H), 1.99 (s, 3H), 1.94 (s, 3H), 1.93 (s, broad,
6H), 1.87 (s, 3H), 1.83-1.80 (m, broad, 3H), 1.64 (s, broad, 9H),
1.60 (s, broad, 6H); 13C NMR (125 MHz, CDCl3) δ 173.8, 170.8,
170.4, 170.3, 170.0, 169.7, 152.0, 86.2, 85.1, 74.0, 71.9, 69.3, 66.2,
63.2, 53.1, 52.7, 50.5, 43.5, 41.5, 35.9, 29.7, 28.2, 26.6, 21.0, 20.8,
20.65, 20.63; ESIHRMS calcd for C35H51N1O14S1Na ([M + Na]+)
764.29228, found 764.29451.
hexanes (1/1) to give donor 3 (1.31 g, 90%): mp 144-145 °C
1
(EtOAc/hexanes); [R]20 ) -78 (c 0.4, CHCl3); H NMR (500
D
MHz, CDCl3) δ 5.69 (t, J ) 2.5 Hz, 1H), 5.29 (td, J ) 2.0, 8.5 Hz,
1H), 4.77-4.66 (m, 3H), 4.14 (dd, J ) 8.0, 12.0 Hz, 1H), 3.83 (s,
3H), 3.66 (dd, J ) 9.5, 11.5 Hz, 1H), 2.79 (dd, J ) 3.5, 13.0 Hz,
1H), 2.47 (s, 3H), 2.17 (t, J ) 13.0 Hz, 1H), 2.12 (s, 3H), 2.10 (s,
3H), 2.01 (s, 3H), 2.03-1.97 (m, broad, 6H), 1.88-1.86 (m, broad,
3H), 1.65 (m, broad, 6H); 13C NMR (125 MHz, CDCl3) δ 172.3,
171.0, 170.6, 169.7, 169.4, 153.7, 85.6, 75.1, 74.1, 73.4, 72.4, 63.3,
60.2, 53.0, 51.3, 43.6, 38.7, 35.9, 29.8, 24.8, 21.2. 20.8, 20.7;
ESIHRMS calcd for C29H39N1O12S1Na ([M + Na]+) 648.20855,
found 648.20983.
Methyl (1-Adamantanyl 5-N,4-O-carbonyl-3,5-dideoxy-2-thio-
D-glycero-â-D-galacto-non-2-ulopyranoside)onate (9). To a solu-
tion of 6 (2.65 g, 3.6 mmol) in methanol (10 mL) was added a
catalytic amount of sodium methoxide. The solution was stirred
for 1 h at room temperature and then quenched with Amberlyst 15
ion-exchange resin. The mixture was filtered through Celite and
concentrated under reduced pressure to give 7. The crude 7 was
treated with trifluoroacetic acid (8.0 mL) for 1 h at room
temperature, and then the mixture was concentrated under reduced
pressure. The concentrate and NaHCO3 (1.50 g, 17.8 mmol) were
dissolved in MeCN (15 mL) and H2O (30 mL) and cooled to 0 °C.
To the vigorously stirred mixture was slowly added 4-nitrophenyl
chloroformate (1.80 g, 8.9 mmol) in MeCN (15 mL) through a
dropping funnel, after which stirring was continued for 3 h at
0 °C. The resulting mixture was extracted with EtOAc (100 mL ×
3), and the combined extracts were washed with brine and then
dried over Na2SO4 and concentrated. The residue was purified by
silica gel column chromatography, eluting with EtOAc then EtOAc/
MeOH from 10/1 to 5/1 to give the title compound 9 as white foam
General Coupling Protocol. A solution of donor (0.11 mmol,
1.0 equiv), acceptor (0.16 mmol, 1.5 equiv), and activated 4 Å
powdered molecular sieves (216 mg, 2.0 g/mmol) in anhydrous
CH2Cl2/MeCN (1/1, 2 mL) was stirred for 1 h under Ar, and then
cooled to -40 °C (or -78 °C) followed by addition of NIS (58.3
mg, 0.26 mmol, 2.4 equiv) and TfOH (9.5 µL, 0.11 mmol, 1.0
equiv). The reaction mixture was stirred at -40 °C (or -78 °C)
for 1 h and then quenched with triethylamine (22.6 µL, 0.16 mmol,
1.5 equiv). The mixture was diluted with CH2Cl2, filtered through
Celite, washed with 20% aqueous Na2S2O3 solution, dried over Na2-
SO4, and concentrated under reduced pressure. The residue was
purified by column chromatography on silica gel eluting with THF/
Hexanes system to afford coupling products, the spectra of which
were identical to those of authentic samples.3
(1.06 g, 2.3 mmol, 65% after three steps): [R]20 ) -162 (c 2.2,
D
MeOH); 1H NMR (500 MHz, MeOD) δ 4.59-4.54 (m, 1H), 4.50
(dd, J ) 2.0, 10.0 Hz, 1H), 3.84 (s, 3H), 3.83 (dd, J ) 2.5, 7.0 Hz,
1H), 3.75-3.68 (m, 2H), 3.57-3.51 (m, 2H), 2.68 (dd, J ) 4.0,
12.5 Hz, 1H), 2.26 (t, J ) 12.5 Hz, 1H), 2.04-1.96 (m, broad,
9H), 1.70 (s, broad, 6H); 13C NMR (125 MHz, MeOD) δ 172.0,
161.0, 86.1, 77.8, 73.8, 70.9, 70.2, 63.5, 58.4, 52.4, 50.2, 43.2, 39.1,
35.8, 30.0; ESIHRMS calcd for C21H31N1O8S1Na ([M + Na]+)
480.16629, found 480.16637.
Acknowledgment. We thank the NIH (GM 62160) for
financial support of this work.
Supporting Information Available: Full experimental details
for the preparation of 2 and copies of NMR spectra for all new
compounds and coupling products. This material is available free
Methyl (1-Adamantanyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-
O-carbonyl-3,5-dideoxy-2-thio-D-glycero-â-D-galacto-non-2-ul-
opyranoside)onate (3). A solution of 9 (1.06 g, 2.3 mmol) in
pyridine (20 mL) was treated with Ac2O (24 mL), stirred at room
JO7012912
J. Org. Chem, Vol. 72, No. 20, 2007 7797